Amyotrophic Lateral Sclerosis (ALS) Therapies
Amyotrophic Lateral Sclerosis (ALS) Market

Amyotrophic Lateral Sclerosis 


Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is a group of rare neurological diseases that mainly involve the nerve cells (neurons), responsible for controlling voluntary muscle movement. Voluntary muscles produce movements like chewing, walking, and talking. The disease is progressive, meaning the symptoms get worse over time. ALS belongs to a broader group of disorders known as motor neuron diseases, which are caused by gradual deterioration and death of motor neurons.


Amyotrophic Lateral Sclerosis Epidemiology Segmentation in the 7MM


  • Prevalent Population of Amyotrophic Lateral Sclerosis
  • Diagnosed Prevalent Population of Amyotrophic Lateral Sclerosis
  • Gender-Specific Population of Amyotrophic Lateral Sclerosis
  • Mutation-Specific Population of Amyotrophic Lateral Sclerosis
  • Type-specific Population of Amyotrophic Lateral Sclerosis
  • Amyotrophic Lateral Sclerosis cases based on Site of Onset
  • Age-specific Population of Amyotrophic Lateral Sclerosis


Amyotrophic Lateral Sclerosis Epidemiological Insights Observed in the 7MM in 2021


  • The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in the 7MM were found to be 52k in the year 2021.
  • The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in the US were observed to be 20.6k cases in the year 2021.
  • The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in Germany were found to be 5.1k in the year 2021, while they were found to be 4k in Italy, and in Spain, they were observed to be 3.1k cases.
  • The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in Japan were estimated to be 10.7k cases in 2021.


Amyotrophic Lateral Sclerosis Market Insight


The market size of Amyotrophic Lateral Sclerosis in the 7MM was found to be approximately USD 460.4 million in 2020.


Amyotrophic Lateral Sclerosis Market Drivers


  • Availability of Epidemiological Data
  • Robust Pipeline Activity
  • Increasing Awareness Programs


Amyotrophic Lateral Sclerosis Market Barriers


  • High Medical Cost
  • Lack of Proper Diagnosis
  • High Mortality Rate
  • No cure, only delaying progression


Amyotrophic Lateral Sclerosis Emerging Therapies


The emerging drugs in the Amyotrophic Lateral Sclerosis market are


  • Tofersen (BIIB067)
  • ION363
  • Ibudilast
  • Masitinib
  • AMX0035
  • EPI-589
  • Verdiperstat
  • Zilucoplan
  • AT-1501
  • RNS60, and many others


Amyotrophic Lateral Sclerosis Key Players 


The key players working in the Amyotrophic Lateral Sclerosis market are


  • Ionis Pharmaceuticals
  • MediciNova
  • Amylyx Pharmaceuticals
  • Seelos Therapeutics
  • Prilenia Therapeutics
  • Biohaven Pharmaceuticals
  • Apellis Pharmaceuticals
  • Eledon Pharmaceuticals
  • NeuroSense Therapeutics
  • Biogen, and many more